Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV001848493 | SCV002105286 | uncertain significance | Hereditary spastic paraplegia | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002543406 | SCV002942739 | likely benign | Spastic ataxia 2 | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002543405 | SCV003615200 | uncertain significance | Inborn genetic diseases | 2022-03-11 | criteria provided, single submitter | clinical testing | The c.1198G>A (p.A400T) alteration is located in exon 14 (coding exon 12) of the KIF1C gene. This alteration results from a G to A substitution at nucleotide position 1198, causing the alanine (A) at amino acid position 400 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |